Condition 1: breast cancer. Condition 2: Genital tract cancer. Carcinoma in situ of breast Female genital organ, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Definitive diagnosis of breast cancer; malignancy based on pathological studies, clinical findings, and physician diagnosis; women treated with Taxon; age between 18 and 60 years; neuropathic pain induced by chemotherapy with a score of 12 or more according to the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale; reading and writing literacy and the ability to speak for the patient or caregiver; having healthy limbs in the legs, especially the sole of the legs or lack of sensory and motor disorders; no drug abuse; non-use of psychotropic drugs; no history of mental illness; informed consent for participation; and the use of prophylaxis drugs for neuropathic pains such as gabapentin and pre-cabalin. Exclusion criteria: Metastasis for bone marrow, lung, liver and kidneys; patient's lack of cooperation until the end of the intervention; and the presence of stressors such as the death of first-degree relatives, divorce, and severe changes in lifestyle over the past 6 months.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Perceived stress. Timepoint: before intervention and 2 weeks after intervention is completed. Method of measurement: Cohen et al.’s Perceived Stress Scale.;Neuropathic pain severity. Timepoint: before intervention and 2 weeks after intervention is completed. Method of measurement: The Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Birjand University of Medical Sciences